Unibest

Pharmaceutical intermediates

Alfacalcidol Intermediates

2 pharmaceutical intermediates for Alfacalcidol. Indication: Vitamin D deficiency; Rickets; Osteoporosis; Hypoparathyroidism.

Submit a ProjectAll intermediates

About Alfacalcidol

Originator
Leo Pharmaceutical Products Ltd
Indication
Vitamin D deficiency; Rickets; Osteoporosis; Hypoparathyroidism
Approved Date
01/01/1978

Available intermediates

2 intermediates currently listed for Alfacalcidol. Request specifications, documentation or a quotation for any item below.

Alfacalcidol intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
[[(1a,3b,5E,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethylsilane]112670-85-6//
BRN 471587565445-14-9//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlogliptin/ Trelagliptin

Building toward Alfacalcidol?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →